BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9291427)

  • 21. Concurrent overexpression of cyclin D1 and cyclin-dependent kinase 4 (Cdk4) in intestinal adenomas from multiple intestinal neoplasia (Min) mice and human familial adenomatous polyposis patients.
    Zhang T; Nanney LB; Luongo C; Lamps L; Heppner KJ; DuBois RN; Beauchamp RD
    Cancer Res; 1997 Jan; 57(1):169-75. PubMed ID: 8988060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential effects of estradiol and its analogs on cyclin D1 and CDK4 expression in estrogen receptor positive MCF-7 and estrogen receptor-transfected MCF-10AEwt5 cells.
    Hong J; Shah NN; Thomas TJ; Gallo MA; Yurkow EJ; Thomas T
    Oncol Rep; 1998; 5(5):1025-33. PubMed ID: 9683804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of cyclin D1 correlates with malignancy in human ovarian tumours.
    Barbieri F; Cagnoli M; Ragni N; Pedullà F; Foglia G; Alama A
    Br J Cancer; 1997; 75(9):1263-8. PubMed ID: 9155044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of G1-->S transition regulatory molecules in human urothelial cancer.
    Oya M; Schmidt B; Schmitz-Dräger BJ; Schulz WA
    Jpn J Cancer Res; 1998 Jul; 89(7):719-26. PubMed ID: 9738978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased expression of G1 cyclins and cyclin-dependent kinases during tumor progression of chemically induced mouse skin neoplasms.
    Zhang SY; Liu SC; Goodrow T; Morris R; Klein-Szanto AJ
    Mol Carcinog; 1997 Mar; 18(3):142-52. PubMed ID: 9115584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas.
    Jares P; Fernández PL; Campo E; Nadal A; Bosch F; Aiza G; Nayach I; Traserra J; Cardesa A
    Cancer Res; 1994 Sep; 54(17):4813-7. PubMed ID: 8062283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclin D1 antisense RNA destabilizes pRb and retards lung cancer cell growth.
    Driscoll B; Wu L; Buckley S; Hall FL; Anderson KD; Warburton D
    Am J Physiol; 1997 Nov; 273(5):L941-9. PubMed ID: 9374720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CDK4/cyclin D1/PCNA complexes during staurosporine-induced G1 arrest and G0 arrest of human fibroblasts.
    Gadbois DM; Peterson S; Bradbury EM; Lehnert BE
    Exp Cell Res; 1995 Sep; 220(1):220-5. PubMed ID: 7664838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aberrant expression of the cell cycle associated proteins TP53, MDM2, p21, p27, cdk4, cyclin D1, RB, and EGFR in cervical carcinomas.
    Skomedal H; Kristensen GB; Lie AK; Holm R
    Gynecol Oncol; 1999 May; 73(2):223-8. PubMed ID: 10329038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclin D1 expression is a major target of the cAMP-induced inhibition of cell cycle entry in fibroblasts.
    L'Allemain G; Lavoie JN; Rivard N; Baldin V; Pouyssegur J
    Oncogene; 1997 Apr; 14(16):1981-90. PubMed ID: 9150365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclin D1 degradation is sufficient to induce G1 cell cycle arrest despite constitutive expression of cyclin E2 in ovarian cancer cells.
    Masamha CP; Benbrook DM
    Cancer Res; 2009 Aug; 69(16):6565-72. PubMed ID: 19638577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4.
    Neuman E; Ladha MH; Lin N; Upton TM; Miller SJ; DiRenzo J; Pestell RG; Hinds PW; Dowdy SF; Brown M; Ewen ME
    Mol Cell Biol; 1997 Sep; 17(9):5338-47. PubMed ID: 9271411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inverse expression of Cdk4 and p16 in epithelial ovarian tumors.
    Sui L; Dong Y; Ohno M; Goto M; Inohara T; Sugimoto K; Tai Y; Hando T; Tokuda M
    Gynecol Oncol; 2000 Nov; 79(2):230-7. PubMed ID: 11063650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin-like growth factor-I induces cyclin-D1 expression in MG63 human osteosarcoma cells in vitro.
    Furlanetto RW; Harwell SE; Frick KK
    Mol Endocrinol; 1994 Apr; 8(4):510-7. PubMed ID: 8052269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deregulated expression of cyclin D1 and other cell cycle-related genes in carcinogen-induced rat mammary tumors.
    Sgambato A; Han EK; Zhang YJ; Moon RC; Santella RM; Weinstein IB
    Carcinogenesis; 1995 Sep; 16(9):2193-8. PubMed ID: 7554074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclin D2 activates Cdk2 in preference to Cdk4 in human breast epithelial cells.
    Sweeney KJ; Sarcevic B; Sutherland RL; Musgrove EA
    Oncogene; 1997 Mar; 14(11):1329-40. PubMed ID: 9178893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical study of cyclins D and E and cyclin dependent kinase (cdk) 2 and 4 in human endometrial carcinoma.
    Ito K; Sasano H; Yoshida Y; Sato S; Yajima A
    Anticancer Res; 1998; 18(3A):1661-4. PubMed ID: 9673386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of the cell-cycle regulatory proteins (pRb, cyclin D1, p16INK4A and cdk4) in human endometrial cancer: correlation with clinicopathological features.
    Semczuk A; Miturski R; Skomra D; Jakowicki JA
    Arch Gynecol Obstet; 2004 Jan; 269(2):104-10. PubMed ID: 14648178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberrant expression of G1-phase cell cycle regulators in flat and exophytic adenomas of the human colon.
    Bartkova J; Thullberg M; Slezak P; Jaramillo E; Rubio C; Thomassen LH; Bartek J
    Gastroenterology; 2001 Jun; 120(7):1680-8. PubMed ID: 11375949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased transforming growth factor beta type II receptor expression in intestinal adenomas from Min/+ mice is associated with increased cyclin D1 and cyclin-dependent kinase 4 expression.
    Zhang T; Nanney LB; Peeler MO; Williams CS; Lamps L; Heppner KJ; DuBois RN; Beauchamp RD
    Cancer Res; 1997 May; 57(9):1638-43. PubMed ID: 9134999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.